FDA recall, , Moderate risk
Blood Bank of Hawaii Apheresis Red Blood Cells, Leukocytes Reduced
Apheresis Red Blood Cells, Leukocytes Reduced were collected from a donor who had traveled to an area endemic for malaria.
Recall ended May 13, 2026. Still check yours.
Summary by Recall Canary from the FDA notice
What happened
Blood Bank Of Hawaii began a recall of Apheresis Red Blood Cells, Leukocytes Reduced on April 24, 2025, because the cells were collected from a donor who had traveled to an area designated as endemic for malaria. The recall involves 2 units distributed in Hawaii. The FDA added the recall to its Enforcement Report on May 13, 2026, and the recall was in the FDA's weekly enforcement report on May 20, 2026.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Compare these details with yours, then check the recall notice to see which units are recalled.
Apheresis Red Blood Cells, Leukocytes Reduced
Recall details
- Company began the recall
- Sold in
- Company
- Blood Bank Of Hawaii
- Hazard
- Blood donor screening
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 98858
- Recall number
- B-0053-2026
- Quantity recalled
- 2 units
All recalls from Blood Bank Of Hawaii
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
In FDA's weekly enforcement report
Listed on Recall Canary
Archived
